Lisata Therapeutics, Inc. (LSTA) Net income 2015–2024
Lisata Therapeutics, Inc. (LSTA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$16.6MFY2024 · since FY2015: -$32.7M → -$16.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$16.6M | +17.0% |
| FY2023 | -$20.0M | +4.1% |
| FY2022 | -$20.8M | +61.6% |
| FY2021 | -$54.2M | -97.4% |
| FY2020 | -$27.5M | -237.0% |
| FY2019 | -$8.2M | +57.9% |
| FY2018 | -$19.4M | -19.8% |
| FY2017 | -$16.2M | -170.4% |
| FY2016 | $23.0M | +170.4% |
| FY2015 | -$32.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LSTA financial trends
LSTA RevenueLSTA Net marginLSTA Gross profitLSTA Gross marginLSTA Operating incomeLSTA Operating marginLSTA Operating cash flowLSTA Free cash flowLSTA Capital expendituresLSTA Return on equityLSTA Stock buybacksLSTA Dividends paidLSTA Total assetsLSTA Total liabilitiesLSTA Shareholders’ equityLSTA overview →